Proactive Investors - Run By Investors For Investors

Feedback to squeeze in more enhancements to TexRAD Lung ahead of CE Mark ruling

A delay to the award of a CE mark for the TexRAD Lung product will have no impact on the company's recently announced deal leading global imaging company.
Medical imaging
The modficiations will assist in the progression of future versions to wider clinical usage

Feedback plc (LON:FDBK), the medical imaging software company, has identified some enhancements to its TexRAD Lung product that will delay the granting of a CE mark.

The company had previously expected the CE mark by the end of this month but this will now not happen after the company came up with several enhancements that will improve the performance of this version of TexRAD.

Feedback said the introduction of these modifications will result in a delay of several weeks before the CE mark for TexRAD Lung is obtained.

Medical devices are required to have a CE mark before they can legally be sold in the European Union. Feedback is obviously confident of obtaining the mark, because it said it does not expect the delay to have any effect on the commercial negotiations that are underway in respect of TexRAD.

In particular, Feedback stressed the delay would have no effect on the schedule of the deal announced at the end of March (see below).

READ Feedback surges after it pencils TexRAD Lung deal

WATCH chairman Dr Alastair Riddell talk about the TexRAD Lung deal and others in the pipeline

Feedback’s subsidiary, Cambridge Computed Imaging, remains in discussions with other leading imaging companies as it attempts to widen the range of potential routes to market for clinical versions of TexRAD.

Why Invest In Feedback plc? Read More Here

Register here to be notified of future FDBK Company articles
View full FDBK profile View Profile

Feedback plc Timeline

Related Articles

Medical Scan
May 18 2017
The CE mark will enable Feedback to market not just to scientists, but radiologists everywhere, which should lead to a marked expansion in sales
ITM Power's first hydrogen station in London
March 27 2017
Electricity to hydrogen conversion technology has the potential to revolutionise the way we store renewable energy.
LED lighting
March 20 2017
Whilst the commercial launch of halcyon is imminent, set for April 1, the AIM-listed firm has already been rolling-out the product via paid-for technology trials

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use